Use of Stratafix Symmetric™ to Prevent Incisional Hernia in Gastrointestinal and Abdominal Surgery

Description

Comparing the use of Stratafix Symmetric™ sutures to standard laparotomy closure sutures.

Conditions

C.Surgical Procedure; Disruption of Wound, Suture

Study Overview

Study Details

Study overview

Comparing the use of Stratafix Symmetric™ sutures to standard laparotomy closure sutures.

A Randomized Controlled Trial Evaluating the Use of Stratafix Symmetric™ to Prevent Incisional Hernia in Gastrointestinal and Abdominal Surgery

Use of Stratafix Symmetric™ to Prevent Incisional Hernia in Gastrointestinal and Abdominal Surgery

Condition
C.Surgical Procedure; Disruption of Wound, Suture
Intervention / Treatment

-

Contacts and Locations

Kalamazoo

West Michigan Cancer Center, Kalamazoo, Michigan, United States, 49007

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Participant is a male or female 18 years of age or older.
  • 2. Participant is a current patient at West Michigan Cancer Center.
  • 3. Participant is undergoing liver, pancreas or biliary or gastrointestinal surgery of a combination of the above, or other major oncological surgery.
  • 4. Participant is willing and able to provide written informed consent before surgery.
  • 1. Participant has hemodynamic instability at the conclusion of the surgery. (These subjects will be deemed disqualified).
  • 2. Participant has history of previous VIH.
  • 3. Participant has a mental condition rendering the subject incapable of understanding the nature, scope and consequences of the study.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

West Michigan Cancer Center,

Gitonga Munene, PRINCIPAL_INVESTIGATOR, West Michigan Cancer Center

Study Record Dates

2026-12